NEURAL DECISION LTD
Company number 13659927 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
NEURAL DECISION LTD - Analysis Report
Company Number: 13659927
Analysis Date: 2025-07-20 17:56 UTC
Financial Health Assessment: NEURAL DECISION LTD (As of 31 October 2024)
1. Financial Health Score: D
Explanation:
The company exhibits several symptoms of financial stress despite maintaining a positive net asset position. Its declining turnover, operating losses, and minimal current assets relative to fixed assets suggest constrained liquidity and operational challenges typical of an early-stage micro-entity navigating growth and market fit.
2. Key Vital Signs (Critical Financial Metrics & Interpretation):
| Metric | 2024 Value | Interpretation |
|---|---|---|
| Turnover (Revenue) | £5,093 | Turnover has declined by nearly 48% from £9,766 in 2023, indicating reduced sales activity. |
| Profit / (Loss) for Period | (£1,751) | Operating loss widened from £40 in 2023, signaling negative profitability and cost pressure. |
| Fixed Assets | £3,000 | Fixed assets are stable but significant relative to total assets, indicating capital investment. |
| Current Assets | £18 | Critically low; suggests minimal liquid resources or short-term receivables on hand. |
| Current Liabilities | £0 | No immediate debts, which is positive for short-term solvency. |
| Net Current Assets | £18 | Very tight working capital; a fragile buffer to cover short-term obligations. |
| Net Assets / Shareholders’ Funds | £3,018 | Positive equity base, slightly improved from £2,959 last year, reflects retained capital. |
| Staff Costs | £6,713 | High relative to turnover, indicating a heavy wage burden for current sales levels. |
| Other Income | £880 | Some non-operating income helped offset losses but is insufficient. |
Vital Signs Summary:
- The company’s "heartbeat" (turnover) is weakening, dropping sharply year-on-year.
- "Breathing" (cash and liquid assets) is shallow, with only £18 in current assets, posing liquidity risk.
- "Vital organs" (net assets) remain intact but show limited growth, reflecting capital maintenance rather than expansion.
- "Symptoms" such as losses and high staff costs indicate operational inefficiencies and possible overextension.
3. Diagnosis: Overall Financial Condition Assessment
NEURAL DECISION LTD is currently in a fragile financial state typical of a micro-entity in early development phases. The company shows symptoms of financial distress due to declining revenues and widening losses, which point to challenges in scaling its business model profitably. The extremely low current assets suggest "weak blood flow" in terms of cash or receivables, risking the company's ability to meet short-term expenses if conditions worsen.
However, the absence of current liabilities and positive net assets ("healthy bone structure") indicate no immediate solvency crisis. The company’s financial health is more akin to a patient with a chronic condition needing urgent lifestyle changes—without intervention, the risk of worsening losses and cash shortages may threaten sustainability.
4. Recommendations: Specific Actions to Improve Financial Wellness
Enhance Revenue Generation:
- Investigate causes of the steep turnover decline; consider targeted marketing, product refinement, or diversifying income streams.
- Leverage the software publishing expertise (SIC 58290) to identify niche markets or subscription models that ensure steady cash inflows.
Cost Rationalization:
- Staff costs are disproportionately high relative to sales—explore flexible staffing or outsourcing to reduce fixed wage burdens.
- Tighten control on other expenses and evaluate cost-benefit of fixed assets to ensure efficient use.
Improve Liquidity:
- Increase working capital by accelerating receivables collection or negotiating supplier payment terms.
- Explore short-term financing options (e.g., overdrafts, invoice financing) cautiously to bolster "cash flow health."
Financial Monitoring & Reporting:
- Implement monthly cash flow forecasts to detect liquidity issues early.
- Regularly review financial "vital signs" to track recovery or deterioration trends.
Strategic Review:
- Consider engaging with a business mentor or financial advisor to reassess business strategy and financial planning.
- Investigate potential grants or government support for micro-entities in the tech/software sector.
Summary:
NEURAL DECISION LTD is a micro-scale software publisher facing financial challenges marked by declining sales and operating losses. Its financial structure shows resilience in net assets but critically constrained liquidity and profitability deficits. Immediate strategic and operational interventions are required to stabilize cash flow and return to growth.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.